Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BORUZU safely and effectively. See full prescribing information for BORUZU. BORUZU® (bortezomib injection), for subcutaneous or intravenous use Initial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
BORUZU is indicated for the treatment of adult patients with multiple myeloma. BORUZU is indicated for the treatment of adult patients with mantle cell lymphoma.
- generic_name
- bortezomib
- product_names
- Bortezomib
- ndc
- 70121-2484, 70121-2484-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en